SOURCES SOUGHT
65 -- NATricare Heartland Medical Material Standardization for Specimen Containers/Collectors
- Notice Date
- 4/19/2007
- Notice Type
- Sources Sought
- NAICS
- 339113
— Surgical Appliance and Supplies Manufacturing
- Contracting Office
- Department of the Air Force, Air Force Materiel Command, 74th Medical Group-Wright Patterson Medical Center, Bldg 830 4881 Sugar Maple Dr, Wright-Patterson AFB, OH, 45433, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- R5-04-19-07-056-SCC
- Response Due
- 5/10/2007
- Archive Date
- 5/10/2007
- Description
- A. General Information TRICARE Heartland Region, TRBO Region 5, a military integrated delivery network, comprised of 5 Army, Navy, and Air Force, medical treatment facilities in Ohio, Illinois, and Kentucky announces a Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Specimen Containers/Collectors. The primary objective of this standardization initiative is to achieve a best value determination that represents the clinically preferred product or source at the best possible price. It is also intended that standardized product be obtained through the DoD Prime Vendor Program. The major facilities in the area include but are not limited to Wright Patterson Air Force Base Ohio, Scott Air Force Base Illinois, Naval Health Clinics of Great Lakes Illinois, Blanchfield Army Community Hospital Ft Campbell Kentucky, and Ireland Army Community Hospital Ft Knox Kentucky. This standardization action is part of the Medical/Surgical Prime Vendor program executed by the Defense Supply Center Philadelphia, Directorate of Medical Materiel. In order to participate your company must have a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the Prime Vendors for the program. This is pursuant to the DAPA clause by which DAPA holders agree to the Standardization process and to allow Prime Vendors to distribute their items. This is a supplement to the Prime Vendor Program and it is not a contract. For additional information regarding DSCP?s Prime vendor program please access their web site at https://dmmonline.dscp.dla.mil The TRBO will provide anticipated volume (quantity) based on historical usage/forecasted requirements. The agreement will be for a base period of two (2) years (24 months) from date of award with three (3) 12-month option periods. Anticipated award date is June 2007. The evaluation will be based on clinical, technical, and pricing factors. The award will be determined utilizing Best value/ trade off criteria. Point of Contact Phyllis Targett 937-257-9075 phyllis.targett@wpafb.af.mil B. Products & Performance Required The Heartland Region is seeking product line items in the category of Specimen Collectors/Containers. The estimated total volume for this region for this product line is $72,732. This is based on historical prime vendor sales for a 12-month period. At the request of the Heartland Region Military Treatment Facilities vendors will provide on-site support and in-servicing, educational resources and tools for clinical use of the product, conversion information, prime vendor order numbers, MSDS information, and itemization of the brands, types and packaging information of the products offered by the vendor. C. Instructions to Offerors DAPA holders interested in participating in this standardization initiative, email your (1) Company name and address, (2) POC (Name and Phone Number, Fax Number, and E-mail address) to phyllis.targett@wpafb.af.mil (937)257-9075 before 4:00 P.M. EST on the date listed for closing on the FBO announcement in order to remain competitive. This process will include vendor requirements of electronic responses to technical criteria, no charge samples for clinical evaluation, and submission of electronic best price offers. Due to the potential for email to be lost in transmission from network security, etc., vendors are strongly encouraged to confirm with the Heartland Region that its initial submission, quote and literature actually arrived at the Region via email. Each submitting vendor is advised to confirm receipt, allowing adequate time for resubmission before 4:00 P.M. EST on the date listed for closing on the FBO announcement in order to remain competitive. Vendors that fail to meet the submittal deadline will be disqualified. D. Evaluation Criteria The Tri-Service Product Review Board (TPRB) is the governing board of the standardization process. This board includes clinicians and logisticians from all of the Military Treatment Facilities within the Heartland Region. They are the decision makers for this initiative. Phase I. Vendors will be required to provide responses to the technical/company criteria. The responses will be reviewed under the purview of the TPRB to determine acceptability. After review of technical/company criteria, those vendors who meet the criteria will be invited to participate in Phase II, the clinical/performance evaluation. All technical/company criteria are equally weighted. Phase II. The TPRB will request samples from the product group to be non-clinically evaluated at select Military Treatment Facilities. Vendors are required to ship samples direct to the MTFs. A three-week period will be allotted to vendors for shipment. Samples must be received by COB at 4PM local time, 21 calendar days after request. Vendors failing to deliver by the deadline will be disqualified from further consideration in the standardization process. Specific MTF?s will evaluate the clinical/performance criteria using a likert like one to five rating scale. One is equal to not acceptable and five is equal to highly acceptable. All criteria are weighted equally. The TPRB has set a 3.75 acceptability threshold for all product groups. Clinical/performance results lower than 3.75 will not be considered acceptable and will be disqualified from further consideration in the standardization process. Phase III. After the clinical/performance evaluation are completed and analyzed, all vendors in the clinical evaluation group who met the 3.75 threshold will be asked to submit their best pricing offer based on committed volume of 80% of the total requirements of the MTFs in the Heartland Region. Vendors who fail to offer discounted prices will be disqualified from RIA award consideration. Clinical/performance factors will be weighted more heavily than price. Pricing will be evaluated based on best value to the government and will be based on a committed volume for a two-year period with possible one-year option periods (not to exceed 5 years). Vendors that fail to offer an incentive discount from DAPA will be disqualified. 1. Technical/Company Criteria Evaluation The TPRB will review the following technical criteria responses from each vendor and determine acceptability. Acceptability for purposes of evaluation of technical/company criteria: Generally responses to all questions in this section demonstrate that: 1) the business concern offering the quote is a distributor or manufacturer of a complete line of the subject medical/surgical consumables; 2) based on the quoter?s responses, the evaluators have reasonable confidence that the line or products and/or services offered meet the medical standards of care of the community, applicable to such products or services; 3) the quoter has, or is obtaining a DAPA for the items; 4) the quoter has, or is obtaining, an agreement covering the items with the Prime Vendor for the region; and 5) the quoter intends to offer discounts off DAPA for all products included in this standardization initiative (vendors that fail to offer a discount from DAPA will be disqualified); and 6) the quoter?s information provided is factually correct (any misrepresentation of information will disqualify the vendor from further consideration.) The TPRB will review the following technical criteria responses from each vendor and determine acceptability: 1. Does your company manufacture specimen containers and collectors? 2. Are your products available through the Prime Vendor for the Region? 3. What is your DAPA Number? 4. Under what brand(s) does your company manufacture or distribute your product? 5. Under what standards is your product manufactured? 6. What types of containers and collectors does your company manufacture? 7. Do you have specimen containers and collectors that are pre-loaded with formalin? 8. Will your company offer discounts off DAPA for all products included in this standardization initiative (note that vendors that fail to offer a discount from DAPA will be disqualified)? 9. Are your specimen containers and collectors made of plastic or a shatterproof material? 10. Are your containers and collectors available in clear, translucent, or opaque material? Please list the type of container and collector that is available in each of the transparencies. 11. Are your products latex free? 12. Do you use non-toxic, color fast dyes for labeling on your products? 13. Do your containers have clearly marked gradients that are easy to read? 14. Do your containers come with wide enough openings for easy transfer from the source to the container? 15. What sizes do your containers and collectors come in? 16. Do your containers have screw caps or snap caps? Are they plastic or metal? 17. Do your specimen containers and collectors contain a closure that can be removed by gripping with fingers? 18. Do your specimen containers and collectors have a surface that can be marked with a ballpoint pen for patient identification information? 19. Do your containers and collectors come sealed and sterile or just clean? 20. Are your containers leak proof? How does the user know the cap is securely placed on the container or collector? 21. Does your company have plastic sealable bags that fit your containers and collectors for transportation from clinical areas to the lab? 22. Can your containers be transported through pneumatic tube systems? 23. How does your company ensure identification of tampering with a sterile container? 24. What is the shelf life of your specimen containers and collectors? 25. How does your company recommend disposal of your containers? Does this method comply with regulations to minimize impact on the environment? 26. What types of educational tools or materials do you have for this product line? 27. What kind of staff training does your company provide? 28. Does your company provide customer service 24/7? 29. Is there any history of backorders and/or recalls for this product group? If yes, please answer: a. Dates and duration b. Cause c. Resolution 2. Clinical/Performance Criteria Evaluation A Clinical Product Team (CPT) comprised of medical professionals from several disciplines will evaluate the products in non-clinical setting based upon on the following evaluation criteria to determine acceptability. 1. The fluid can be easily viewed in the container. 2. The labeling and gradation scale is easy to read. 3. The cap can be easily secured to the container. 4. The cap to the container does not leak. 5. The package is easy to open and allows for aseptic delivery to the sterile field. 6. The size and type of the container or collector is easily identified from the packaging.
- Place of Performance
- Address: , 88th Medical Group/ MDSS/ SGSL/ TRBO, 4881 Sugar Maple Dr., Bldg 830, Wright-Patterson AFB, OH, ,
- Zip Code: 45433
- Country: UNITED STATES
- Zip Code: 45433
- Record
- SN01276915-W 20070421/070419220803 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |